Head-to-Head

Johnson & Johnson vs. Nektar Therapeutics

JNJ

Johnson & Johnson

$270.47 +1.25%

VS NKTR

Nektar Therapeutics

$30.20 -7.19%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

JNJNKTR
Market Cap $651.11 billion $1.11 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

JNJNKTR
Dividend Yield 1.98% —

JNJ and NKTR split the dividend factors evenly.

Risk & Sentiment

JNJNKTR
Short Interest 0.67% 31.24%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, NKTR overview, NKTR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.